Washington [US], May 7 (ANI/Sputnik) : The WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) urged the pharmaceutical industry to open access to clinical data for all new medicines and vaccines for reasons of "overriding public health interest."